News

Doctors from The Alfred Interventional Radiology (IR) team, headed up by principal investigator Associate Professor Jim Koukounaras, have designed a world-first study using interventional radiology to treat endometriosis.

When Natalie started experiencing involuntary jerks in 2020, she had no idea the journey she had begun. Following a tonic-clonic seizure and a misdiagnosis of epilepsy, Natalie eventually discovered she had functional neurological disorder (FND). Daily, she was experiencing clusters of jerks – about 50 at a time – and as a busy professional, Natalie felt her body was out of her control. 

Heart patients of the future are set to benefit from a new partnership which will bring together the combined strengths of three leading institutions in cardiovascular research and patient care.

When COVID-19 antivirals were first introduced, prescribers had a lot of questions. The Alfred Pharmacy team stepped in to answer them – setting up a state-wide helpline in less than two weeks.

We were pleased to welcome our research partners from Monash University recently for a tour of the Paula Fox Melanoma and Cancer Centre building site.

The Alfred is the home for clinical trials and translational health practice. Of all clinical trials happening in Australia, one in five occur on site at The Alfred. The Alfred does two thirds of all first-in-human clinical trials conducted in Australia. That's why, this World Clinical Trials Day, we are celebrating the researchers, partners and collaborators who choose to conduct their trials with Alfred Health. 

The stroke team at The Alfred is delighted to be the first in Victoria to receive Australian Stroke Coalition Stroke Unit Certification.

Each year, thousands of Australian women undergo invasive and life-altering hysterectomies to treat debilitating pain and blood loss caused by uterine fibroids. But there’s another option: a very safe, pin-hole procedure that cures the symptoms, yet leaves the uterus intact.

Two Alfred heart experts have today declared a new method of donor heart preservation a gamechanger for heart transplantation in Australia and New Zealand. 

In an Australian first, The Alfred Intensive Care Unit (ICU) is now home to a mobile computed tomography (CT) scanner. With no other ICU in the country using mobile CT, the installation of the machine in 2022 was the culmination of a six-year project to revolutionise the way ICU patients, especially those who need head CT scans, are cared for. Costing just more than $1 million to purchase and install, the project could never have been achieved without the $850,000 generously contributed by the community.